BG102476A - Полиморфни форми за усилване секрецията на хормона на растежа - Google Patents

Полиморфни форми за усилване секрецията на хормона на растежа

Info

Publication number
BG102476A
BG102476A BG102476A BG10247698A BG102476A BG 102476 A BG102476 A BG 102476A BG 102476 A BG102476 A BG 102476A BG 10247698 A BG10247698 A BG 10247698A BG 102476 A BG102476 A BG 102476A
Authority
BG
Bulgaria
Prior art keywords
forms
polymorphous forms
secretagogue
phenylmethoxy
propanamide
Prior art date
Application number
BG102476A
Other languages
English (en)
Inventor
Jerome DRAPER
David DUBOST
Michael Kaufman
James Mccauley
Jennifer VANDRILLA
Richard Varsolona
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603361.8A external-priority patent/GB9603361D0/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of BG102476A publication Critical patent/BG102476A/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Fodder In General (AREA)

Abstract

Изобретението се отнася до полиморфни форми на съединението N-[1(R)-[(1,2-дихидро-1-метансулфонилспиро[3Н-индол-3,4'-пипердин]-1'-ил)карбонил]-2-(фенилметилокси)етил]-2-амино-2-метил-пропанамид метансулфонат. То е секретагог на растежен хормон и е полезно при хранене на животни за ускоряване на растежа им, като по този начин се повишава ефективността при производството на хранителни месни продукти. При хора се използва за третиране на физиологични или медицински състояния, характеризиращи се с намалена секреция на растежен хормон, и на медицински състояния, които се подобряват от анаболни ефекти на растежен хормон. Моментните полиморфни форми имат предимство пред други познати форми на N-[1(R)-[(1,2-дихидро-1-метансулфонилспиро [3Н-индол-3,4'-пипердин]-1'-ил)карбонил]-2-(фенилметокси)етил]-2-амино-2-метил-пропанамид метансулфонат по отношение на термодинамична стабилност и с това, че саподходящи за включване във фармацевтични формулировки. Изобретението се отнася също и до процесите на получаване на тези полиморфни форми, до фармацевтични формулировки, които ги включват като активни съставки, и до използването на полиморфните форми на съединението и техни формулировки за третиране на някои отклонения.
BG102476A 1995-10-27 1998-05-21 Полиморфни форми за усилване секрецията на хормона на растежа BG102476A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US590095P 1995-10-27 1995-10-27
GBGB9603361.8A GB9603361D0 (en) 1996-02-16 1996-02-16 Polymorphic forms of a growth hormone secretagogue
PCT/US1996/016955 WO1997015574A1 (en) 1995-10-27 1996-10-23 Polymorphic forms of a growth hormone secretagogue

Publications (1)

Publication Number Publication Date
BG102476A true BG102476A (bg) 1999-04-30

Family

ID=26308741

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102476A BG102476A (bg) 1995-10-27 1998-05-21 Полиморфни форми за усилване секрецията на хормона на растежа

Country Status (22)

Country Link
EP (1) EP1019402A1 (bg)
JP (1) JP3204266B2 (bg)
KR (1) KR19990067098A (bg)
CN (1) CN1067687C (bg)
AU (1) AU707946B2 (bg)
BG (1) BG102476A (bg)
BR (1) BR9611229A (bg)
CA (1) CA2235371A1 (bg)
CO (1) CO4770956A1 (bg)
CZ (1) CZ128098A3 (bg)
EA (1) EA000528B1 (bg)
EE (1) EE9800147A (bg)
HK (1) HK1017894A1 (bg)
HU (1) HUP9902208A3 (bg)
IS (1) IS4721A (bg)
NO (1) NO310556B1 (bg)
NZ (1) NZ321370A (bg)
PL (1) PL327511A1 (bg)
SK (1) SK51398A3 (bg)
TR (1) TR199800726T2 (bg)
WO (1) WO1997015574A1 (bg)
YU (1) YU56696A (bg)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046333A (en) * 1996-10-25 2000-04-04 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO115804B1 (ro) * 1992-12-11 2000-06-30 Merck & Co Inc Derivati de spiropiperidine, procedee de preparare si compozitii farmaceutice ale acestora

Also Published As

Publication number Publication date
HK1017894A1 (en) 1999-12-03
CN1067687C (zh) 2001-06-27
PL327511A1 (en) 1998-12-21
BR9611229A (pt) 1999-05-25
NZ321370A (en) 1999-11-29
AU7468696A (en) 1997-05-15
KR19990067098A (ko) 1999-08-16
CN1205703A (zh) 1999-01-20
JPH10512295A (ja) 1998-11-24
NO981867L (no) 1998-06-29
NO310556B1 (no) 2001-07-23
EA199800335A1 (ru) 1998-12-24
EA000528B1 (ru) 1999-10-28
HUP9902208A2 (hu) 1999-10-28
CZ128098A3 (cs) 1998-09-16
AU707946B2 (en) 1999-07-22
HUP9902208A3 (en) 2001-05-28
SK51398A3 (en) 1998-12-02
NO981867D0 (no) 1998-04-24
WO1997015574A1 (en) 1997-05-01
IS4721A (is) 1998-04-21
TR199800726T2 (xx) 1998-08-21
CO4770956A1 (es) 1999-04-30
CA2235371A1 (en) 1997-05-01
EE9800147A (et) 1998-12-15
EP1019402A1 (en) 2000-07-19
YU56696A (sh) 1999-09-27
JP3204266B2 (ja) 2001-09-04
MX9803351A (es) 1998-09-30

Similar Documents

Publication Publication Date Title
CA2110670A1 (en) Spiro piperidines and homologs which promote release of growth hormone
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
HU0102272D0 (en) Compositions and methods for stimulating gastrointestinal motilis
MY131457A (en) Spiro piperidines and homologs promote release of growth hormone
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
ES8402313A1 (es) Procedimiento para la obtencion de derivados de carboxilamida n-glicosilados.
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
HUT70055A (en) Process for preparing pharmaceutical compositions of immunomodulating activity containing cystine derivatives
AU5232193A (en) Spiro piperidines and homologs promote release of growth hormone
HUT45531A (en) Process for producing bactericidal compositions, fodder additives and 7-azabicycloalkyl-quinolonecarboxylic acid and naphthiridinecarboxylic acid derivatives applicable as active ingredient
MX9706689A (es) Tratamiento de trastornos causados por el factor de crecimiento de citocina.
WO2001026650A3 (en) Use of n-acyl homoserine lactones for the treatment of cardiac tachyarrhythmias, ischaemic heart disease or congestive heart failure
ZA931677B (en) Process for the preparation of beta-phenylisoserine and analogues thereof
GB9109972D0 (en) Therapeutic compounds
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
BG102476A (bg) Полиморфни форми за усилване секрецията на хормона на растежа
AU558679B2 (en) Animal feed composition comprising alyl peptides
BR9911756A (pt) Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto
EP1200432A4 (en) AMIDO-SPIROPIPERIDINES PROMOTING THE RELEASE OF GROWTH HORMONE
CO4930262A1 (es) Producto farmaceutico cristalino, su preparacion y uso como sustancia terapeutica
ATE184489T1 (de) Behandlung fehlender milchabsonderung beim menschen
RU93048128A (ru) Стимулирование роста свиней
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
MX9803316A (es) Procedimiento para preparar un secretagogo de hormona de crecimiento.